Regis Healthcare Limited Overview
Regis Healthcare is Australia's only remaining ASX-listed, pure-play residential aged care operator. Its scale platform comprises 72 wholly freehold homes with about 8,230 beds across six states and the Northern Territory. It also has a growing home care business and a small retirement living arm. The model is vertically integrated: Regis identifies sites, develops, operates and renews its homes. It funds growth largely from interest-free Refundable Accommodation Deposits (RADs), which totalled A$2.28bn at FY26.
Since late 2023, Regis has been the sector's most active consolidator, adding 13 homes and more than 1,700 beds. It is also building a nine-site greenfield pipeline of about 1,300 beds aimed at more than 10,000 beds. Revenue is about 73% government-funded. Earnings therefore depend heavily on Canberra's annual AN-ACC care-pricing decisions, which caused 26–27% one-day share price falls in both September 2025 and September 2026.
The investment case rests on three things: structural undersupply of beds, accommodation pricing power, and RAD retention under the new Aged Care Act.
Company's own description
In its 2026 Annual Report, Regis describes itself as a leading provider of aged care and services for older people. It says it supports more than 10,000 people through residential aged care, home care, day therapy, respite services and retirement living, with a workforce of more than 13,000 [AR26].
The Directors' Report sets out six pillars of its business model [AR26]:
Care delivery: Supporting care staff to deliver a home-like care experience.
Well-resourced risk management: Covering clinical governance, legislative compliance and health and safety.
Vertical integration: Catchment analysis, site identification and acquisition, brownfield and greenfield development, home operation and asset renewal.
Strong cash flow generation: Including receipt and use of RADs to repay acquisition and development debt.
High-quality portfolio: Mainly metropolitan locations with high median house prices and a high proportion of single rooms.
Scalable platform: IT systems and in-house resources that support growth through acquisitions and developments.
What the company does (independent characterisation)
Regis is a capital-intensive, labour-intensive, government-regulated care operator. It owns its real estate and earns two broad types of return:
-
Operating care and services income. Government funding plus resident fees, which together pay for care, everyday living and accommodation services.
-
Balance-sheet funding from RADs. Residents who pay a lump-sum accommodation deposit effectively provide interest-free funding. This funding is refundable on departure.
The balance-sheet effect is very large. The RAD liability was A$2,279.1M at FY26, more than 1.6× annual revenue [FY26R]. Net RAD cash inflow of A$250.5M in FY26 was nearly twice underlying EBITDA of A$138.0M [FY26R].
Under the new Aged Care Act (from 1 Nov 2025), providers keep 2% a year of RADs from new residents for up to five years. This converts part of the RAD float into recurring earnings. Regis projects more than A$50M a year once fully phased in [FY26R].
Revenue model
| Revenue type | FY26 AUD Mn | Share of revenue from services | Nature |
|---|---|---|---|
| Government funded (AN-ACC care funding, hotelling supplement, other supplements, home care funding) | 991.7 | 73.4% | Regulated service fees |
| Resident basic daily fees | 183.7 | 13.6% | Regulated, indexed resident contribution |
| Other resident revenue (means-tested / non-clinical care contribution, DAP/DAC, HELF and legacy additional services) | 168.2 | 12.5% | Partly market-priced services |
| Other operating revenue | 5.7 | 0.4% | Ancillary |
| Deferred management fees (retirement living) | 1.4 | 0.1% | Property-style contractual fees |
All figures below are FY26, from [AR26].
The business has no product sales, licensing or subscription revenue in the conventional sense. Its mix is about 99.9% services.
The "Other income" line is separate from revenue from services. It totalled A$188.9M in FY26 [AR26] and includes:
-
Imputed (non-cash) income on RADs of A$153.5M. This is required under AASB 16 and is fully offset by an equal imputed interest charge.
-
A gain on disposal of A$25.5M.
-
Interest income of A$6.7M.
Value chain position and customers
Regis sits at the provider and operator end of the aged care value chain. Funding flows from the Commonwealth, and from residents and families, through Regis to its workforce (staff expenses are 78.1% of revenue [FY26R]) and to suppliers such as food, clinical systems and construction.
Customer types
-
Residents in permanent care, respite, specialist dementia (memory support) and palliative care.
-
Home care clients under Support at Home, the Commonwealth Home Support Programme (CHSP) and private arrangements.
-
Retirement village residents (428 at 30 June 2026 [AR26]).
-
The Australian Government as the main payer.
End-markets. Australian residential aged care, community-based home care and retirement living. Regis has no offshore operations.
Strategy
Stated strategy: "Purposeful Change 2025–2027" (launched Aug 2024) [AR26]
Vision and purpose. The vision is to lead aged care "with hearts and minds". The purpose is personalised, respectful care that embraces the experience of ageing. Values: Optimism, Passion, Integrity, Respect.
Three pillars
-
Care and Service Excellence. Trusted professionals, personalised care and quality built environments.
-
A Responsible Business. Accountable compliance, disciplined financial management and a sustainable property portfolio.
-
Future Ready. Innovation, agility, scalable systems and sustainability.
Three enablers. An integrated model of care; an innovative education and training model; and digital innovation, including AI.
Five growth priorities
-
Targeted growth in quality residential beds through acquisitions, greenfield and brownfield development.
-
Best-in-class lifestyle and Higher Everyday Living services.
-
Exploring innovative aged care models.
-
Excellence in concierge, hospitality and dining.
-
Accelerating home care into a scalable national business.
Achievements in the first two years of the strategy [AR26]:
-
Four businesses acquired, adding 8 homes, 1,092 beds and about 800 home care clients.
-
Camberwell opened, and the greenfield pipeline expanded from 3 to 9 sites.
-
New clinical, HR, catering and generative AI platforms implemented.
-
A new palliative care model introduced.
Initiatives in the last 24 months
| Initiative | Date | Description / target | Status |
|---|---|---|---|
| Bed growth target | FY25 to FY26 | 10,000 beds by FY28 [FY25R]; restated as "beyond 10,000 beds" [FY26R] | About 8,230 beds at FY26 |
| Greenfield program | Ongoing | 9 sites and about 1,300 beds; target of 2–3 new developments a year [H1FY26 call]; Toowong (123 beds) opens summer 2026/27 | 2 sites under construction |
| FY27 capex | FY27 | More than A$150M, excluding land [FY26C] | Guidance |
| Room repricing | Jul–Aug 2026 | About 70% of rooms repriced, about +10% average advertised price; more than A$500M of potential net operating cash inflow over time [FY26R] | Executed |
| RAD retention | From 1 Nov 2025 | More than A$50M a year once fully phased in (about five years) [FY26R]; A$1.3M in FY26 | Ramping |
| HELF transition | Nov 2025 – Nov 2026 | Existing residents move to HELF by 1 Nov 2026; FY27 a transition year | In progress |
| Telstra Health clinical management system | FY26–CY26 | CareKeeper mobile app; 56% of homes live at 30 Jun 2026; full rollout by end CY2026 [AR26] | In progress |
| Coupa procurement; Microsoft Fabric analytics | FY26 | Spend control and enterprise analytics [AR26] | Implemented |
| AI-enabled recruitment | FY26 | Turnover in participating roles down 56% in the first 157 days; about 7,300 recruiter hours saved [AR26] | Live |
| Simple Foods digital catering | FY26 | Rollout complete across all homes [AR26] | Complete |
| Portfolio recycling | FY26 | Exit of regional, end-of-life homes (Ayr, Home Hill, Weston, Bulimba) | Ongoing |
| Home care scale-up | FY25–FY27 | BodeWell (Apr 2025); Royal Freemasons (closing Q2 FY27); annualised home care revenue about A$50M | Pending completion |
| Workforce | FY26 | Turnover 18%, engagement 86%, CLTIFR 5.79 [AR26] | Achieved |
| Gender equality | FY26 | WGEA median gender pay gap of 0% [AR26] | Achieved |
Medium-term targets and guidance
| Item | Guidance / target | Source |
|---|---|---|
| FY26 underlying EBITDA | A$130–135M (set Sep 2025), later "about A$135M"; actual A$138.0M | [FU0925]; [TU0426]; [FY26R] |
| FY27 underlying EBITDA | No formal guidance; update to follow if material, including after AN-ACC decisions | [FY26C] |
| FY27 staff costs | About 78% of revenue, assuming AN-ACC is neutral | [FY26C] |
| FY27 greenfield completions | 3–4 projects (Toowong, Carlingford, Coburg cited on the call). The Annual Report wording suggests Coburg construction starts in FY27, so the sources are inconsistent. | [FY26C]; [AR26] |
| Beds | More than 10,000 | [FY26R] |
Products & Services
Residential Aged Care
| Offering | Description and capabilities | Target customer | Pricing / funding model |
|---|---|---|---|
| Permanent residential care | 24/7 nursing and personal care in 72 homes. Care minutes rose from 178.8 a day (Q4 FY23) to 226.7 (Q4 FY25) [FY23R; FY25R]. | Older Australians assessed as needing residential care | AN-ACC per resident per day. Starting price A$295.64 from Oct 2025, A$303.19 from 1 Oct 2026 [ANACC26]. |
| Accommodation | Rooms priced as a RAD or a Daily Accommodation Payment (DAP). Average incoming RAD in FY26 was A$697,200, up 20% [FY26R]. | Non-supported (means-assessed) residents | Market-priced up to the regulated maximum: A$750,000 from Jan 2025, indexed to A$789,686 from 1 Jul 2026 [FY26R]. About 70% of rooms were repriced up about 10% in Jul–Aug 2026 [FY26R]. 2% a year RAD retention for new residents from 1 Nov 2025. |
| Supported resident accommodation | Accommodation for low-means residents | Concessional / supported residents | Government accommodation supplement. A new tiered system is due Mar 2027, with a further A$20 increase from Mar 2028 for homes with more than 60% concessional residents [AR26]. |
| Everyday living (hotelling) | Food, laundry and cleaning | All residents | Hotelling supplement A$22.15 a day, raised about 42% in Sep 2025 and held flat from Oct 2026 [AR26; ANACC26]. Basic daily fee averaged A$64.10 in FY26. Means-tested co-contribution for new residents from Nov 2025. |
| Higher Everyday Living Fee (HELF) | Optional premium services such as dining, concierge and lifestyle. Replaced "Additional Services" and "Extra Services" on 1 Nov 2025. Existing residents transition by 1 Nov 2026. | Residents choosing premium services | Resident-paid. Management called FY27 a transition year for HELF [FY26C]. |
| Respite care | Short-stay residential respite | Carers and families | AN-ACC respite classes |
| Specialist dementia / memory support | Secure memory support units, being refurbished into smaller "neighbourhoods" (e.g. Wynnum, Ontario, Playford) [AR26] | Residents living with dementia | AN-ACC |
| Palliative care | New palliative care model introduced under the 2025–27 strategy [AR26] | End-of-life residents | AN-ACC |
| Texture-modified dining | Partnership with The Pure Food Co; Simple Foods digital catering platform rolled out across all homes [AR26] | Residents with dysphagia or special diets | Included in care and hotelling |
Flagship and new homes
| Home | Beds | Status | Notes |
|---|---|---|---|
| Regis Camberwell (VIC) | 112 | Opened 6 Nov 2024 | 99% occupancy by end-FY26; net RAD inflow of A$42.1M in FY26 [FY26R; AR26] |
| Regis Oxley (QLD, ex-Rockpool) | 150 | Opened Mar 2025; acquired Sep 2025 | Ramp-up completed within 12 months; net RAD inflow of A$55.8M in FY26 [FY26R] |
| Regis Carseldine, Morayfield, Pelican Waters (QLD) | Part of the 600 Rockpool beds | Acquired Sep 2025 | All opened within the past six years [AR26] |
| Regis Torquay and Regis Drysdale (VIC) | 230 combined | Acquired Dec 2025 | 100% single ensuite rooms; built or extensively refurbished within eight years [AR26] |
| Regis Capel Sound and Regis Mornington (VIC) | 170 and 92 | Acquired Dec 2024 | Formerly Village Glen [Regis release] |
| Regis Toowong (QLD) | 123 | Under construction | Opening planned for summer 2026/27 [FY26R] |
| Regis Carlingford (NSW) | — | Under construction | Completion expected in FY27 [H1FY26 call] |
| Coburg (VIC), Essendon (VIC), Parkside (SA), Bulimba (QLD) | — | Approved or in planning | Construction start estimated in FY27 [Investing.com, FY26 slides] |
| Newport, Seaford (VIC), Shenton Park / "Regis Montario" (WA) | — | Planning | Shenton Park site acquired in FY26 [AR26] |
Home Care
| Offering | Description | Target customer | Funding |
|---|---|---|---|
| Support at Home | Nursing, allied health, daily living help, meals, social support and respite in the home. Eight funding classifications from 1 Nov 2025 [AR26]. | Older people ageing in place | Government-funded with co-contributions. Personal care becomes fully government-funded from Oct 2026. Planned price caps were deferred indefinitely on 19 May 2026 [AR26]. |
| Commonwealth Home Support Programme (CHSP) | Entry-level support (acquired via BodeWell and Royal Freemasons) | Lower-needs clients | Block or grant funded |
| Private home care | Fee-for-service | Self-funded clients | Market price (not disclosed) |
| Home care hubs | Cairns, South East Queensland, Darwin, Eastern Metro Melbourne, Mildura, Tasmania South and North [AR26] | Regional and metro clients | As above |
| Day therapy and day respite | Day Therapy Centre Townsville; Day Therapy Centre Nedlands (WA); Health and Wellness Centre Port Coogee (WA) [AR26] | Community clients and carers | Mix of CHSP and private (not disclosed) |
Retirement Living
| Village | State | Notes |
|---|---|---|
| Regis Bramble Bay | QLD | Independent living [AR26] |
| Regis Corinthian Court | QLD | Independent living [AR26] |
| Regis Woodward | QLD | Independent living [AR26] |
| Regis Inala | VIC (Blackburn South) | Independent living [AR26] |
| Regis Norwood | TAS | Independent living [AR26] |
The retirement portfolio is valued as investment property; FY26 fair value gain was A$1.9M [AR26]. Revenue comes from deferred management fees (A$1.4M in FY26).
Financial Narrative
Income statement
Sources: [FY23R], [4E23], [FY24R], [FY25R], [FY26R], [AR26] (five-year highlights). FY22 statutory NPAT is from Kalkine's data table and matches the FY22 EPS of –12.9c in [FY23R].
DPS composition
-
FY22: 3.52c interim + 2.32c final.
-
FY23: 2.00c + 7.48c.
-
FY24: 6.28c + 6.64c.
-
FY25: 8.09c + 8.13c.
-
FY26: 9.00c + 9.40c.
Sources: [H1FY22], [4E23], [H1FY24], [4E25], [FY26R].
Unavailable or not applicable
Gross profit: not reported, because Regis presents expenses by nature. Simply Wall St shows a derived FY25 gross profit of A$141.5M, which is not company-defined.
Operating income: the closest company measure is underlying EBIT.
Margins and growth
Sources: as above. The FY25 and FY26 occupancy figures are for all homes [AR26]; mature-home occupancy was 95.6% and 96.0% respectively.
Revenue CAGR FY22–FY26: 16.8% a year (derived: 1,350.6 / 725.3 over four years).
Underlying EBITDA CAGR FY22–FY26: 15.3% a year (derived).
Balance sheet
Sources: [AR26] five-year highlights and Directors' Report; [4E23]; [4E25].
They are disclosed in the FY26 Annual Report financial statements.
Net tangible assets are structurally negative. This is because RADs, which are interest-free resident deposits, are held as current liabilities while the homes are carried at cost.
Debt maturity [AR26]
-
A$182.1M facility matures March 2028.
-
A$180.0M facility matures March 2029.
-
At FY26, effectively all of the facility was undrawn (A$361.5M of A$362.1M).
Cash flow
Sources: [FY23R], [FY24R], [FY25R], [AR26].
Acquisition consideration by year
-
FY24: CPSM, A$75.1M.
-
FY25: Ti Tree A$40.3M plus BodeWell A$4.4M.
-
FY26: Rockpool A$138.4M plus OC Health A$44.7M.
FY26 detail
-
Dividends paid were A$24.5M (FY25 final) plus A$27.2M (FY26 interim) [AR26].
-
Capex included A$55.6M of land settlements, A$42.5M on greenfield developments and A$40.2M on refurbishment [FY26R].
-
No buyback program has been disclosed.
Ratios
All ratios are derived from the tables above.
The cash conversion cycle is not meaningful for a service operator with prepaid and deposit-funded receipts.
Structural notes on the ratios
-
The current ratio is structurally below 1, because RADs are classified as current liabilities under accounting standards even though turnover is gradual.
-
Statutory ROE was depressed through FY24 by bed licence amortisation, which ended in FY24.
Commentary on trends, inflections and drivers
Revenue. Revenue nearly doubled from A$725.3M in FY22 to A$1,350.6M in FY26. There were three drivers:
-
AN-ACC funding, which replaced ACFI in October 2022, plus IHACPA-indexed pricing increases that funded the Fair Work Commission wage decisions and care minutes.
-
Occupancy rising from 89.8% to 95.8%.
-
Acquisitions. CPSM contributed A$52M in its first seven months [The Weekly SOURCE, Aug 2024]. Rockpool and OC Health contributed A$79.0M and A$17.5M of FY26 revenue respectively [AR26].
Excluding acquisitions, AN-ACC indexation of 2.6% from 1 Oct 2025 added more than A$40M in FY26. The higher hotelling supplement (average rate rising from about A$12 to about A$21 per resident per day) added about A$20M [FY26C].
Margins. Underlying EBITDA margin has been stuck at about 10–11% despite large revenue growth. This is because:
-
Government funding increases are largely passed through to wages under the Fair Work Commission Work Value Case and the Annual Wage Review.
-
Care-minute mandates are fixed costs.
The FY26 margin fell 0.6 points to 10.2%, and staff costs reached 78.1% of revenue. The company attributes this to the October 2025 AN-ACC indexation, which carried no margin uplift. The CFO estimated the hit at about A$10M of FY26 earnings [The Weekly SOURCE, 23 Feb 2026].
The September 2026 indexation of 2.55% compares with award increases of 4.75% from 1 Jul 2026 and nurse rises of 1.5–4.4% from 1 Aug 2026 [The Bull, 3 Sep 2026]. This points to a further squeeze in FY27, partly offset by:
-
RAD retention.
-
Room repricing.
-
HELF.
-
Lower turnover (18% in FY26 against 40% in FY23) and reduced agency labour.
Profitability inflection. Statutory NPAT turned from losses in FY22–FY24 (bed licence amortisation, COVID costs) to A$49.0M in FY25 and A$55.7M in FY26. Underlying NPAT growth slowed sharply in FY26 to 4%, from 37% in FY25, because:
-
Depreciation stepped up (Camberwell and acquisitions).
-
Finance costs rose.
-
Interest income was lower after cash was deployed.
Cash and balance sheet. The company is very cash-generative, but cash flow is dominated by RADs. RAD inflows were A$250.5M in FY26, and the combined underlying EBITDA plus net RAD inflow grew from A$127M in FY23 to A$388M in FY26 [FY26C].
Operating cash flow excluding RADs fell to A$85.8M in FY26. Likely reasons include tax payments, acquisition stamp duty (A$10.1M) and working capital; this is not explained in the sources reviewed. After A$326.1M invested in capex and acquisitions [AR26], net cash still ended at A$173.8M.
Management says progressive repricing of existing paid-up RADs to current prices could release more than A$500M of net operating cash inflow over time [FY26R]. This is a forward-looking estimate.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Service Line Details
| Service line (management description) | What it contains | Scale at 30 Jun 2026 [AR26] |
|---|---|---|
Residential Aged Care | 72 freehold homes offering permanent care, ageing in place, respite, specialist dementia (memory support units) and palliative care | About 8,230 available places; 7,891 residents |
Home Care | Support at Home (replaced Home Care Packages and Short-Term Restorative Care on 1 Nov 2025), CHSP and private services, plus day respite and day therapy centres | 2,626 clients. Annualised revenue was about A$30M after BodeWell [ASX, Jan 2025], expected to reach about A$50M after Royal Freemasons [Capital Brief, Aug 2026]. |
Retirement Living | 5 independent living villages with more than 400 units | 428 residents |
Revenue stream (AUD Mn)
| Revenue stream (AUD Mn) | FY25 | FY26 |
|---|---|---|
Government funded | 865.7 | 991.7 |
Resident basic daily fees | 163.6 | 183.7 |
Other resident revenue | 123.5 | 168.2 |
Other operating revenue | 6.8 | 5.7 |
Deferred management fees | 1.7 | 1.4 |
Revenue from services (total) | 1,161.3 | 1,350.6 |
Stream growth and mix (%)
| Stream growth and mix (%) | FY25 | FY26 |
|---|---|---|
Government funded YoY growth | — | 14.5 |
Resident basic daily fees YoY growth | — | 12.3 |
Other resident revenue YoY growth | — | 36.2 |
Government funded share of revenue | 74.5 | 73.4 |
Resident basic daily fees share | 14.1 | 13.6 |
Other resident revenue share | 10.6 | 12.5 |
Revenue by Segment (AUD)
| Metric (AUD per resident per day) | FY25 | FY26 |
|---|---|---|
Government revenue | 323.30 | 343.11 |
Resident basic daily fee | 63.20 | 64.10 |
Other resident revenue | 47.01 | 59.03 |
Revenue by Segment and Segment Margins & Growth (%)
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue from services | 725.3 | 780.6 | 1,014.1 | 1,161.3 | 1,350.6 |
Underlying EBITDA | 78.1 | 83.3 | 107.2 | 125.8 | 138.0 |
Underlying EBITDA margin (%) | 10.8 | 10.7 | 10.6 | 10.8 | 10.2 |
Revenue YoY growth (%) | — | 7.6 | 29.9 | 14.5 | 16.3 |
Revenue by Segment and Segment Margins & Growth (%) (Half-Yearly)
| Metric (AUD Mn) | H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 |
|---|---|---|---|---|
Revenue from services | 564.2 | 597.1 | 667.7 | 682.9 |
Underlying EBITDA | 68.1 | 57.7 | 70.6 | 67.4 |
Underlying EBITDA margin (%) | 12.1 | 9.7 | 10.6 | 9.9 |
Income Statement and Financial Ratios (x)
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue from services | 725.3 | 780.6 | 1,014.1 | 1,161.3 | 1,350.6 |
Other income (incl. imputed RAD income) | — | — | — | 130.9 | 188.9 |
Imputed income on RADs (non-cash) | — | — | — | 111.2 | 153.5 |
Staff expenses | — | — | — | 889.0 | 1,055.1 |
Staff expenses derived from disclosed ratio | 550.5 | 590.9 | 776.8 | 889.0 | 1,055.1 |
Underlying EBITDA | 78.1 | 83.3 | 107.2 | 125.8 | 138.0 |
Reported EBITDA (company definition) | — | — | — | 120.8 | 142.4 |
Depreciation excl. right-of-use assets | — | — | — | 48.5 | 54.8 |
Underlying EBITA | — | 39.6 | 61.5 | — | — |
Underlying EBIT | — | — | — | 77.3 | 83.2 |
Other finance costs (excl. imputed RAD interest) | — | — | — | 8.0 | 10.7 |
Profit before tax (statutory) | — | — | — | 71.4 | 83.7 |
Income tax expense (derived) | — | — | — | 22.5 | 28.0 |
Statutory NPAT | -38.8 | -28.5 | -21.4 | 49.0 | 55.7 |
Underlying NPAT | 20.6 | 20.4 | 38.9 | 53.4 | 55.6 |
Basic EPS statutory (cents) | -12.9 | -9.5 | -7.11 | 16.25 | 18.44 |
Underlying basic EPS (cents) | — | — | — | 17.73 | 18.42 |
Dividends per share (cents) | 5.84 | 9.48 | 12.92 | 16.22 | 18.40 |
Margin Analysis (%)
| Ratio (%) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Underlying EBITDA margin | 10.8 | 10.7 | 10.6 | 10.8 | 10.2 |
Underlying NPAT margin | 2.8 | 2.6 | 3.8 | 4.6 | 4.1 |
Statutory net margin | -5.3 | -3.6 | -2.1 | 4.2 | 4.1 |
Underlying EBIT margin | — | — | — | 6.7 | 6.2 |
Staff expenses / revenue | 75.9 | 75.7 | 76.6 | 76.6 | 78.1 |
Revenue growth | — | 7.6 | 29.9 | 14.5 | 16.3 |
Underlying EBITDA growth | — | 6.7 | 28.7 | 17.4 | 9.7 |
Effective tax rate (derived) | — | — | — | 31.5 | 33.5 |
Average occupancy, all homes | 89.8 | 91.5 | 94.1 | 95.1 | 95.8 |
Balance Sheet and Per-Share Data
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Net cash (positive) / net debt (negative) | -102.9 | -6.0 | 64.9 | 192.5 | 173.8 |
RAD liability | — | — | — | 1,826.4 | 2,279.1 |
Bank facility limit | — | — | — | 367.1 | 362.1 |
Undrawn bank facility | — | — | — | — | 361.5 |
Average cash balance held | — | — | — | 180.1 | 159.1 |
Employee underpayment remediation provision | — | — | — | 20.8 | 12.9 |
NTA per share (cents) | -95.5 | -88.5 | -129.6 | -148.7 | — |
Cash Flow
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Net operating cash flow (incl. RADs) | 114.8 | 105.2 | 252.3 | 306.1 | 336.3 |
Net RAD / bond cash inflow | 83.9 | 43.6 | 141.0 | 195.4 | 250.5 |
Operating cash flow excl. net RADs (derived) | 30.9 | 61.6 | 111.3 | 110.7 | 85.8 |
Capital expenditure | 48.6 | 53.5 | 66.9 | 88.1 | 143.1 |
Free cash flow incl. RADs (derived) | 66.2 | 51.7 | 185.4 | 218.0 | 193.2 |
Free cash flow excl. RADs (derived) | -17.7 | 8.1 | 44.4 | 22.6 | -57.3 |
Acquisitions, net consideration | — | — | 75.1 | 44.7 | 183.1 |
Net cash used in investing | — | — | — | -132.7 | -301.4 |
Net cash used in financing | — | — | — | -45.8 | -53.5 |
Dividends paid | — | — | — | — | 51.7 |
Share buybacks | 0 | 0 | 0 | 0 | 0 |
Financial Ratios (x) and Returns & Leverage Ratios (%)
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Net debt / underlying EBITDA (x; negative = net cash) | 1.32 | 0.07 | -0.61 | -1.53 | -1.26 |
Interest cover: underlying EBIT / other finance costs (x) | — | — | — | 9.7 | 7.8 |
RAD liability / revenue (x) | — | — | — | 1.57 | 1.69 |
Net RAD inflow / underlying EBITDA (x) | 1.07 | 0.52 | 1.32 | 1.55 | 1.82 |
Dividend payout of underlying EPS (%) | — | — | — | 91.5 | 99.9 |
Region revenue (AUD Mn)
| Region revenue (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Australia | 725.3 | 780.6 | 1,014.1 | 1,161.3 | 1,350.6 |
Australia YoY growth (%) | — | 7.6 | 29.9 | 14.5 | 16.3 |
State / Territory Details
| State / territory | Residential homes | Development sites | Retirement villages | Home care / day centres |
|---|---|---|---|---|
Queensland | 29 | 2 | 3 | 3 |
Victoria | 21 | 4 | 1 | 2 |
Western Australia | 8 | 1 | 0 | 2 |
New South Wales | 6 | 1 | 0 | 0 |
South Australia | 4 | 1 | 0 | 0 |
Tasmania | 3 | 0 | 1 | 2 |
Northern Territory | 1 | 0 | 0 | 1 |
Total | 72 | 9 | 5 | 10 |
Revenue by Region and Operating Metrics (millions)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Available beds at year end | 6,897 | 6,888 | 7,461 | 7,588 | 8,224 |
Occupied bed days (millions) | — | 2.332 | 2.517 | 2.616 | 2.85 |
Net RAD cash inflow (AUD Mn) | 83.9 | 43.6 | 141.0 | 195.4 | 250.5 |
Share Price History
| Date | Price (AUD) | Context | Source |
|---|---|---|---|
Late Aug 2023 | 2.40 | Around FY23 results | Inside Ageing |
13 Sep 2024 | 5.85 | Aged care reform deal | MT Newswires |
2 Dec 2024 | 6.55 | Ti Tree completion | MT Newswires |
25 Aug 2025 | 8.56 | FY25 results (2025 peak about A$9.22–9.40) | Capital Brief; Motley Fool |
22 Sep 2025 | 6.80 | Funding update, –26% | Inside Ageing |
22 Dec 2025 | 7.32 | At CEO resignation release | InvestSMART |
23 Feb 2026 | 6.90 | H1 FY26, +8% intraday | Capital Brief |
24 Aug 2026 | 6.76 | FY26 results, +5.8% | Investing.com |
3 Sep 2026 | 4.30 | AN-ACC 2.55%, –27% | The Bull / Reuters |
13 Oct 2026 | 4.42 | Latest verified close | ad-hoc-news |
Share Price & Returns
| Period | Approx. return (%) | Basis |
|---|---|---|
1-year | -35 | From A$6.80 (22 Sep 2025, nearest verified point) to A$4.42 |
3-year | 84 | From about A$2.40 (Aug 2023) to A$4.42 |
Dividend metric
| Dividend metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
DPS (cents) | 5.84 | 9.48 | 12.92 | 16.22 | 18.40 |
Franking (%) | 50 | 50 | 50 | 65 | 100 |
DPS growth (%) | — | 62.3 | 36.3 | 25.5 | 13.4 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market capitalisation | A$1,336M | 302.36M shares |
Enterprise value (excl. RAD liability) | A$1,162M | Market cap less FY26 net cash of A$173.8M |
P/E (statutory FY26 EPS 18.44c) | 24.0× | Yahoo shows a trailing P/E of about 24× |
P/E (underlying FY26 EPS 18.42c) | 24.0× | — |
EV / underlying EBITDA FY26 | 8.4× | Excludes RADs (interest-free resident funding) |
EV / revenue FY26 | 0.86× | — |
Broker / Aggregator Details
| Broker / aggregator | Rating | Target (AUD) | Date |
|---|---|---|---|
Consensus (6 ratings, CMC Invest via Motley Fool) | Mixed | 6.08 average | 12 Oct 2026 |
Yahoo consensus | — | 6.07 average (range 5.00–7.40) | Oct 2026 |
Median of broker targets (ad-hoc-news) | — | 6.09 (range 5.05–7.77) | 11 Sep 2026 |
UBS (David Low) | Neutral | 5.95 (from 6.75); EPS cut 14% | 3 Sep 2026 |
RBC Capital Markets | Hold | 5.00 | 15 Sep 2026 |
Analyst Conclusions
Management guidance (FY27)
-
No formal EBITDA guidance has been given [FY26C].
-
Staff costs are expected at about 78% of revenue if AN-ACC is neutral. The 2.55% indexation announced after the results makes this assumption look optimistic.
-
Capex is expected to exceed A$150M excluding land.
-
Three to four greenfield completions are expected, starting with Toowong (123 beds) in summer 2026/27.
-
RAD retention earnings should step up from A$1.3M.
-
HELF is in transition through Nov 2026.
-
Royal Freemasons completion is expected in Q2 FY27.
Consensus
-
Following the September 2026 funding decision, brokers cut forecasts. UBS reduced its EPS forecast by 14%.
-
The average price target is about A$6.08, which implies about 38% upside from A$4.42. The range is wide (A$5.00–7.77), signalling high dispersion.
Bull case
-
Structural scarcity converts to pricing. About 10,600 beds are needed a year against about 1,500 being added. With 96% mature occupancy and a 20% rise in incoming RADs, Regis can keep pushing accommodation prices, as the 10% repricing of 70% of rooms shows.
-
RAD retention compounds. More than A$50M a year of retention earnings at full run-rate would be about 36% of FY26 underlying EBITDA. It is high-margin and largely insulated from AN-ACC decisions.
-
Balance sheet funds self-sustaining growth. Net cash of A$173.8M, A$361.5M undrawn, more than A$500M of potential repricing cash release and more than A$250M a year of RAD inflows allow acquisitions and greenfield builds without equity dilution, at about 8.4× EV/EBITDA after a 27% de-rating.
Bear case
-
Policy treadmill. Two consecutive years of AN-ACC indexation (about 2.6% and 2.55%) below wage growth of about 3.5–4.75% plus Work Value Case rises compress care margins. EBITDA margin has already fallen from 10.8% to 10.2%, with the second half at 9.9%.
-
Earnings quality. FY26 statutory NPAT included a A$25.4M divestment gain. Operating cash flow excluding RADs fell to A$85.8M, and free cash flow excluding RADs was negative A$57.3M. Underlying EPS grew only 3.9% despite 16% revenue growth.
-
Transition and execution risk. A new CEO and CFO, HELF migration, more than A$150M of capex, construction risk and new Aged Care Act compliance all land in FY27, while the hotelling supplement is frozen at A$22.15.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst |
|---|---|
| 17 Nov 2026 | AGM: CEO's first strategic commentary; possible FY27 outlook; Monaghan election |
| Nov 2026 | HELF transition deadline for existing residents (1 Nov) and resulting take-up |
| Q2 FY27 | Royal Freemasons completion |
| Summer 2026/27 | Toowong opening and ramp-up (RAD inflows) |
| Feb 2027 | H1 FY27 results: margin trajectory after the 2.55% indexation; RAD retention run-rate |
| Mar 2027 | New tiered accommodation supplement starts |
| 2026–27 | Government response to the Accommodation Pricing Review (RAD retention rate, greenfield loans) |
| Ongoing | Acquisition announcements; any confirmation or denial of consolidation rumours |
| Sep 2027 | FY28 AN-ACC indexation decision, the single largest share price driver |
Analyst verdict
Regis enters FY27 as a fundamentally strong operator trapped inside an unfavourable pricing regime.
Operationally the evidence is compelling. FY26 revenue rose 16% to A$1.35bn and underlying EBITDA reached A$138.0M, ahead of guidance. Mature occupancy held at 96%, turnover fell to 18%, and two acquisitions totalling 830 beds were integrated quickly. The balance sheet is unusually robust for the sector: net cash of A$173.8M, a near-fully undrawn A$362M facility, and RAD inflows of A$250.5M that recycled more than half of the Rockpool purchase price within a year.
Yet the equity has twice lost about a quarter of its value in a single session because of decisions made in Canberra. That pattern is a structural feature, not a one-off. With about 73% of revenue government-funded and staff costs at 78% of revenue, every gap between indexation and wage outcomes falls straight through to a margin that is only about 10%.
The September 2026 decision of 2.55% against award increases of about 4.75% makes FY27 care margins likely to contract further. FY26 statutory profit was also flattered by a A$25.4M asset-sale gain.
The offset is that Regis' earnings mix is shifting toward levers it controls:
-
Accommodation repricing.
-
RAD retention (more than A$50M a year at maturity).
-
HELF.
-
Home care.
-
A greenfield pipeline of about 1,300 beds in a market adding only about 1,500 beds a year nationally.
At about 8.4× EV/EBITDA, about 24× earnings and about a 4.2% fully franked yield, the market is pricing in persistent policy hostility.
Verdict: positive-skewed, high-variance hold. The long-term thesis (scarcity, pricing power and self-funded growth) is intact and arguably cheaper. However, a re-rating likely requires either explicit funding reform or clear evidence by the H1 FY27 result that RAD retention and repricing are offsetting care-margin erosion.
Key monitorables:
-
The new CEO's first strategic signals at the 17 November 2026 AGM.
-
Toowong's ramp-up.
-
The government's response to the Accommodation Pricing Review.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education |
|---|---|---|---|---|
Andrew Kinkade | Managing Director & CEO | Appointed 29 Apr 2026; commenced 20 Jul 2026 | MD, Bupa Villages & Aged Care (about 8,000 staff, 57 locations); director of Bupa Hong Kong; executive roles at Bupa Dental Care, Catholic Healthcare and National Home Doctor Service; Bain & Company; Macquarie Group (London) | LLB (First Class Hons) and BAcc, University of Technology Sydney; member of AICD |
Stuart Hooper | Chief Financial Officer | From 1 Sep 2026 | CFO, Bupa Asia Pacific; nine years at Ventia (mostly as Group CFO); more than ten years at PwC (M&A and assurance) | — |
Rick Rostolis | CFO (retired 31 Aug 2026) | Mar 2020 – Aug 2026 | CEO/CFO at SMS Management & Technology; CFO at Pro-Pac Packaging | BBus (Accountancy); FCA; GAICD |
Jenn Armor | Chief Operating Officer | Since Feb 2026 | More than 20 years in aviation and banking (customer strategy, digital, operations) | BBus & Accountancy; CA ANZ; GAICD |
Dr Imtiaz Bhayat | Chief Information Officer | Since 2020 | Tier-one consulting | PhD (Financial Markets Technology); MCom; MRes; BCom; CPA |
Filomena Ciavarella | EGM, Strategy & Care Excellence | Since 2020 | Royal Children's Hospital, Peter MacCallum, Monash Health, Austin Health, Mercy Health | BSc (Hons, Medical Radiations); MBA |
Jodie Haydon | Chief People Officer | Since Aug 2024 | Shell, Viva Energy Australia, Energy Australia | BEc; GAICD |
Malcolm Ross | General Counsel & Company Secretary | Since Nov 2021 | Listed-company General Counsel roles | BBus; LLB; LLM |
Georgia Willis | EGM, Property (including ESG) | Since 2023 | Urban infill and renewal pre-development | Master of Property |
Lisa Pendlebury | GM Corporate Development (investor contact) | — | — | — |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Appointed | Independence | Committees | Background |
|---|---|---|---|---|---|
Graham Hodges (age about 71) | Chair | NED Aug 2017; Chair 1 Jul 2018 | Independent | People, Remuneration & Nomination (PRNC); Audit, Risk & Compliance (ARCC) | Former Deputy CEO of ANZ; ANZ board until Feb 2026; Commonwealth Treasury; IMF |
Andrew Kinkade | MD & CEO | 20 Jul 2026 | Executive | — | See above |
Prof. Christine Bennett AO (age about 70) | NED | Mar 2018 | Independent | Chair, Clinical Governance & Care Committee (CGCC); ARCC; Property | Paediatrician; NED of Sonic Healthcare; Australian Digital Health Agency board |
Sally Freeman | NED | Jan 2022 | Independent | Chair, ARCC; PRNC; CGCC | Former Partner in Charge, KPMG Risk Consulting; NED of Netwealth |
Ian Roberts | NED (co-founder) | Director since listing (Oct 2014) | Not independent (substantial holder of about 27%) | Chair, Property; PRNC | Property developer; about 35 years in real estate |
Jodie Leonard (age about 59) | NED | Nov 2023 | Independent | Chair, PRNC; Property; CGCC | GE, Nine Network, British Airways, Telstra; former NED of Pacific Smiles and XPON |
Carmel Monaghan | NED | 1 Feb 2026 | Independent | Property; CGCC | Former CEO of Ramsay Health Care Australia; NED of EMVision; Chair of Metro South HHS (from Apr 2026); stands for election at the Nov 2026 AGM |
Board of Directors — Graham Hodges
| Name | Role | Total remuneration (AUD) | Period / source |
|---|---|---|---|
Graham Hodges | Chair | 290,000 | Board fee, Simply Wall St (latest disclosed year, likely FY25) |
Christine Bennett | NED | 200,000 | Same basis |
Sally Freeman | NED | 200,000 | Same basis |
Jodie Leonard | NED | 191,000 | Same basis |
Ian Roberts | NED | 180,000 | Same basis |
Rick Rostolis | CFO | 1,350,000 | Total, Simply Wall St (latest disclosed year) |
Linda Mellors | Former CEO | — | Mellors received rights vesting of 419,690 shares (Oct 2025) and an issue of 115,236 shares (Dec 2025) per Motley Fool insider data. |
Andrew Kinkade | CEO | — | — |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
22 Dec 2025 | CEO Mellors resigns (six-month notice) | Left for a career outside aged care, later confirmed as InvoCare; shares fell 1–2% |
Feb 2026 | Jenn Armor joins as COO | New operations leadership |
29 Apr 2026 | Andrew Kinkade appointed CEO | Korn Ferry-run search |
13 Jul 2026 | CFO Rostolis announces retirement effective 31 Aug 2026 | Planned transition |
20 Jul 2026 | Kinkade commences and joins the Board | — |
24 Aug / 1 Sep 2026 | Stuart Hooper appointed CFO, effective 1 Sep 2026 | Second senior hire from Bupa |
Major Shareholders
| Holder | Stake (%) | Shares | Date / source |
|---|---|---|---|
Ian Roberts (co-founder, NED) | 27.1 | 81,910,479 | MarketScreener / Simply Wall St; latest available, reaffirmed 2025–26 |
Bryan Dorman / Ashburn Pty Ltd (Dorman Family Trust) | 10.7–10.8 | 32,205,238 | After the A$133M block sale on 28 Jul 2025 (The Weekly SOURCE); Simply Wall St |
River Capital Pty Ltd | 6.35 | 19,194,187 | Substantial holder notice, 2 Sep 2026 (Investing.com) |
Australian Retirement Trust | 5.48 | 16,582,238 | 3 Aug 2026 (Investing.com) |
Cooper Investors | about 4.9 | — | — |
Pengana Capital | about 1.75 | — | Older MarketScreener data |
Mandala Holdings | about 1.05 | 3,180,000 | MarketScreener |
Bank of America (Merrill Lynch) | 6.54 at last notice (2024) | Not applicable | — |
Other holders ranked 6–10 | — | — | See the FY26 Annual Report top-20 list |
“—” = not publicly disclosed.
Competitive Landscape
Key Competitors
| Competitor | Segment | Ownership | Scale (where verifiable) | Relative positioning vs Regis |
|---|---|---|---|---|
Bupa Villages & Aged Care | Residential aged care, retirement villages | Bupa (UK mutual) | About 57 locations and about 8,000 staff (from Kinkade's biography, 2026) | Similar scale and premium focus; Regis' new CEO and CFO both come from Bupa |
Estia Health | Residential aged care | Bain Capital (taken private in 2023) | 78 homes after buying three Calvary homes in Dec 2024 (The Weekly SOURCE) | Closest listed-era peer; now private; subject of merger rumours |
Opal HealthCare | Residential aged care | Private (consortium) | — | Scale competitor; merger rumours |
Calvary (incl. former Japara) | Residential and home care, hospitals | Church-affiliated not-for-profit | — | Took Japara private (2021); diversified health provider |
Ozcare | Aged and home care (QLD) | Not-for-profit | — | Buyer of Regis' Far North Queensland homes; regional QLD competitor |
Uniting / UnitingCare | Residential and home care | Church not-for-profit | — | Large not-for-profit with home care breadth |
Anglicare (various dioceses) | Residential and home care | Church not-for-profit | — | Metro competitor in NSW |
BaptistCare | Residential and home care | Not-for-profit | — | NSW/ACT competitor |
Southern Cross Care | Residential and retirement | Not-for-profit (state entities) | — | Multi-state competitor |
Arcare | Residential aged care | Private | — | Premium VIC/QLD competitor |
TLC Healthcare | Residential and allied health (VIC) | Private | — | Melbourne premium competitor |
Silverchain (with KinCare) | Home care | Not-for-profit | — | Leading home care scale player; acquired KinCare in 2024 (LevinPro) |
Rockpool (residual development business) | Residential development (SE QLD) | Private | Three development sites retained after selling four homes to Regis | Potential future competitor or acquisition source in SE QLD |
Peer Comparison FY2026
| Metric | Regis (FY26) | Estia Health | Bupa Villages & Aged Care |
|---|---|---|---|
Revenue | A$1,350.6M | Not publicly disclosed (private since 2023) | Not disclosed separately |
Revenue growth | +16.3% | — | — |
Underlying EBITDA margin | 10.2% | — | — |
R&D intensity | Not applicable (not reported) | Not applicable | Not applicable |
Homes | 72 | 78 (Dec 2024) | About 57 locations |
“—” = not publicly disclosed.



